Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

December 19, 2025
The appeal of a dual-parasite combination vaccine
December 19, 2025
The future looks bright for malaria prevention
December 4, 2025
Disease outbreak survivors are key to future preparedness

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
November 19, 2025
Can AI safely support mental health?
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. Opinion: GenAI for global health — the bear and the bull case
    Dr. Bilal Mateen, PATH’s Chief AI Officer, highlights GenAI’s potential in diagnostics, disease surveillance, and health communication while addressing challenges like data privacy and equity.
    Published: December 2024
  2. Life-saving advances in vaccines pave the way for healthier futures
    Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
  3. Why global health organizations are hiring chief AI officers
    Nikolaj Gilbert, President and CEO of PATH, shares insights on the growing trend of global health organizations appointing Chief AI Officers (CAIOs) to harness the transformative potential of artificial intelligence in healthcare.
    Published: September 2024
  4. The first vaccine for malaria received major regulatory approval in 2015.
    The first vaccine for malaria received major regulatory approval in 2015. It didn’t become part of vaccination programs in Africa until 2024. PATH's Ashley Birkett speaks about the manufacturing plans that GSK had put in place were derailed.
    Published: July 2024
Previous
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

991 Item s
991 Item s
    Date
    From
    To
  1. Bio Farma receives marketing authorization for new rotavirus vaccine
    PATH’s Sustaining Vaccine Manufacturing program supported Bio Farma in reaching this crucial milestone, which can expand rotavirus protection for young children across Indonesia.
    Published: October 2026
    Announcement
  2. Join us for Inside Global Health | Lifeline: The Story of PEPFAR
    How did an ambitious idea become one of the most consequential global health commitments in history? And what will it take to sustain that kind of commitment today?
    Published: October 2026
    Announcement
  3. Join PATH and the HepC3P project at the 14th International Conference on Health and Hepatitis in Substance Users
    At the 14th International Conference on Health and Hepatitis in Substance Users, PATH will highlight our work introducing innovative Hepatitis C virus prevention products and approaches, as well as roadmaps for advancing essential harm reduction services globally.
    Published: September 2026
    Press Release
  4. PATH and Global Fund take stock of antimalarial efficacy studies
    The Global Fund to Fight AIDS, Tuberculosis, and Malaria selects PATH to landscape, assess, and support antimalarial therapeutic efficacy studies across Sub-Saharan Africa.
    Published: September 2026
    Announcement
  5. PATH selected to lead Global Fund Integrated Surveillance grant
    The Global Fund to Fight AIDS, Tuberculosis and Malaria selects PATH to lead the Sustainable and Integrated Data Systems grant to support integration efforts in Zambia, Senegal, and Ghana.
    Published: September 2026
    Announcement
Next